These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 20361197)

  • 1. CB1 receptor inhibition leads to decreased vascular AT1 receptor expression, inhibition of oxidative stress and improved endothelial function.
    Tiyerili V; Zimmer S; Jung S; Wassmann K; Naehle CP; Lütjohann D; Zimmer A; Nickenig G; Wassmann S
    Basic Res Cardiol; 2010 Jul; 105(4):465-77. PubMed ID: 20361197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of diet-induced atherosclerosis and endothelial dysfunction in apolipoprotein E/angiotensin II type 1A receptor double-knockout mice.
    Wassmann S; Czech T; van Eickels M; Fleming I; Böhm M; Nickenig G
    Circulation; 2004 Nov; 110(19):3062-7. PubMed ID: 15277329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deletion of angiotensin II type 2 receptor exaggerated atherosclerosis in apolipoprotein E-null mice.
    Iwai M; Chen R; Li Z; Shiuchi T; Suzuki J; Ide A; Tsuda M; Okumura M; Min LJ; Mogi M; Horiuchi M
    Circulation; 2005 Sep; 112(11):1636-43. PubMed ID: 16145000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimulation of the AT2 receptor reduced atherogenesis in ApoE(-/-)/AT1A(-/-) double knock out mice.
    Tiyerili V; Mueller CF; Becher UM; Czech T; van Eickels M; Daiber A; Nickenig G; Wassmann S
    J Mol Cell Cardiol; 2012 Mar; 52(3):630-7. PubMed ID: 22230040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heart rate reduction by ivabradine reduces oxidative stress, improves endothelial function, and prevents atherosclerosis in apolipoprotein E-deficient mice.
    Custodis F; Baumhäkel M; Schlimmer N; List F; Gensch C; Böhm M; Laufs U
    Circulation; 2008 May; 117(18):2377-87. PubMed ID: 18443241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-6 induces oxidative stress and endothelial dysfunction by overexpression of the angiotensin II type 1 receptor.
    Wassmann S; Stumpf M; Strehlow K; Schmid A; Schieffer B; Böhm M; Nickenig G
    Circ Res; 2004 Mar; 94(4):534-41. PubMed ID: 14699015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin II induces vascular endocannabinoid release, which attenuates its vasoconstrictor effect via CB1 cannabinoid receptors.
    Szekeres M; Nádasy GL; Turu G; Soltész-Katona E; Tóth ZE; Balla A; Catt KJ; Hunyady L
    J Biol Chem; 2012 Sep; 287(37):31540-50. PubMed ID: 22787147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-atherosclerotic effects of serelaxin in apolipoprotein E-deficient mice.
    Tiyerili V; Beiert T; Schatten H; Camara B; Jehle J; Schrickel JW; Nickenig G; Andrié RP
    Atherosclerosis; 2016 Aug; 251():430-437. PubMed ID: 27341752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atheroprotection via cannabinoid receptor-2 is mediated by circulating and vascular cells in vivo.
    Hoyer FF; Steinmetz M; Zimmer S; Becker A; Lütjohann D; Buchalla R; Zimmer A; Nickenig G
    J Mol Cell Cardiol; 2011 Dec; 51(6):1007-14. PubMed ID: 21884703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C-reactive protein upregulates angiotensin type 1 receptors in vascular smooth muscle.
    Wang CH; Li SH; Weisel RD; Fedak PW; Dumont AS; Szmitko P; Li RK; Mickle DA; Verma S
    Circulation; 2003 Apr; 107(13):1783-90. PubMed ID: 12665485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin II-induced activation of central AT1 receptors exerts endocannabinoid-mediated gastroprotective effect in rats.
    Gyires K; Rónai AZ; Zádori ZS; Tóth VE; Németh J; Szekeres M; Hunyady L
    Mol Cell Endocrinol; 2014 Feb; 382(2):971-8. PubMed ID: 24145131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of direct thrombin inhibition with dabigatran on plaque formation and endothelial function in apolipoprotein E-deficient mice.
    Lee IO; Kratz MT; Schirmer SH; Baumhäkel M; Böhm M
    J Pharmacol Exp Ther; 2012 Nov; 343(2):253-7. PubMed ID: 22837011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvement of endothelial function in a murine model of mild cholesterol-induced atherosclerosis by mineralocorticoid antagonism.
    Kratz MT; Schirmer SH; Baumhäkel M; Böhm M
    Atherosclerosis; 2016 Aug; 251():291-298. PubMed ID: 27439215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of oxidative stress and AT1 receptor expression by the selective oestrogen receptor modulator idoxifene.
    Bäumer AT; Wassmann S; Ahlbory K; Strehlow K; Müller C; Sauer H; Böhm M; Nickenig G
    Br J Pharmacol; 2001 Oct; 134(3):579-84. PubMed ID: 11588112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Superoxide dismutase mimetic M40403 improves endothelial function in apolipoprotein(E)-deficient mice.
    Jiang F; Guo Y; Salvemini D; Dusting GJ
    Br J Pharmacol; 2003 Jul; 139(6):1127-34. PubMed ID: 12871831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin II impairs neurovascular coupling in neocortex through NADPH oxidase-derived radicals.
    Kazama K; Anrather J; Zhou P; Girouard H; Frys K; Milner TA; Iadecola C
    Circ Res; 2004 Nov; 95(10):1019-26. PubMed ID: 15499027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effects of AT1 receptor blocker, olmesartan, and estrogen on atherosclerosis via anti-oxidative stress.
    Tsuda M; Iwai M; Li JM; Li HS; Min LJ; Ide A; Okumura M; Suzuki J; Mogi M; Suzuki H; Horiuchi M
    Hypertension; 2005 Apr; 45(4):545-51. PubMed ID: 15723967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulation of angiotensin II-AT1 receptors during statin withdrawal in vascular smooth muscle cells.
    Castejon AM; Zollner E; Tristano AG; Cubeddu LX
    J Cardiovasc Pharmacol; 2007 Dec; 50(6):708-11. PubMed ID: 18091590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular mechanisms of irbesartan suppressing atherosclerosis in high cholesterol-diet apolipoprotein E knock-out mice.
    Yao R; Cheng X; Chen Y; Xie JJ; Yu X; Liao MY; Ding YJ; Tang TT; Liao YH
    Int J Cardiol; 2010 Mar; 139(2):113-22. PubMed ID: 19028402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heart rate reduction with ivabradine improves erectile dysfunction in parallel to decrease in atherosclerotic plaque load in ApoE-knockout mice.
    Baumhäkel M; Custodis F; Schlimmer N; Laufs U; Böhm M
    Atherosclerosis; 2010 Sep; 212(1):55-62. PubMed ID: 20347444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.